1168 Identification of fully human TCR-mimic antibodies targeting the KRAS G12V/HLA complex generated in HLA-transgenic RenMabTM mice

• Yi Yang,
• Yue Zhang,
• Yuqi Zhang,
• Han Chen,
• Limin Zhao,
• Jun Du,
• Baihong Liu,
• W Frank An,
• Chaoshe Guo,
• Wanbo Tang,
• Xin Jiao,
• Pengfei Du,
• Jian Bao,
• Aijing Niu

Affiliations

Yi Yang

1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Yue Zhang

1Stony Brook University, Stony Brook, NY, USA

Yuqi Zhang

1Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX, USA

Han Chen

Department of Information, Medical Security Center, Hainan Hospital, PLA General Hospital, Sanya, China

Limin Zhao

Shanghai Children’s Hospital, Department of Otolaryngology and Head and Neck Surgery, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Jun Du

1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Baihong Liu

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

W Frank An

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Chaoshe Guo

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Wanbo Tang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Xin Jiao

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Pengfei Du

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Jian Bao

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Aijing Niu

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China